Studies released in recent weeks are fueling optimism — and fresh questions — about GLP-1 drugs' potential role in cancer ...
He’s not the only doctor — or patient — having second thoughts. The risks and benefits of common screenings, procedures, and ...
Learn more Rezolute’s second Phase III trial of ersodetug, this time in tumour hyperinsulinism (HI), is yielding more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results